Ultragenyx strikes deal with struggling Abeona for rare disease gene therapy

Rare disease drugmaker Ultragenyx Pharmaceutical has acquired an experimental gene therapy for Sanfilippo syndrome Type A, licensing rights to the treatment from struggling developer Abeona Therapeutics in an agreement announced Tuesday.